1. Quan, Jing, Bode, Ann M, Luo, Xiangjian. 2021. ACSL family: The regulatory mechanisms and therapeutic implications in cancer. In European journal of pharmacology, 909, 174397. doi:10.1016/j.ejphar.2021.174397. https://pubmed.ncbi.nlm.nih.gov/34332918/
2. Lai, Zhenyu, Li, Shipeng, Wu, Fei, Lei, Chuzhao, Dang, Ruihua. 2020. Genotypes and haplotype combination of ACSL3 gene sequence variants is associated with growth traits in Dezhou donkey. In Gene, 743, 144600. doi:10.1016/j.gene.2020.144600. https://pubmed.ncbi.nlm.nih.gov/32217139/
3. Tan, Shirong, Sun, Xiangyu, Dong, Haoran, Xu, Ling, Xu, Yingying. . ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis. In Cancer biology & medicine, 21, 606-35. doi:10.20892/j.issn.2095-3941.2023.0309. https://pubmed.ncbi.nlm.nih.gov/38953696/
4. Migita, Toshiro, Takayama, Ken-Ichi, Urano, Tomohiko, Takahashi, Satoru, Inoue, Satoshi. 2017. ACSL3 promotes intratumoral steroidogenesis in prostate cancer cells. In Cancer science, 108, 2011-2021. doi:10.1111/cas.13339. https://pubmed.ncbi.nlm.nih.gov/28771887/
5. Wang, Sijiao, Song, Yansha, Xu, Fan, Fu, Yipeng, Zhu, Lei. 2023. Identification and validation of ferroptosis-related genes in lipopolysaccharide-induced acute lung injury. In Cellular signalling, 108, 110698. doi:10.1016/j.cellsig.2023.110698. https://pubmed.ncbi.nlm.nih.gov/37149072/
6. Ma, Mingzhe, Kong, Pengfei, Huang, Yakai, Du, Chunyan, Yang, Hui. 2022. Activation of MAT2A-ACSL3 pathway protects cells from ferroptosis in gastric cancer. In Free radical biology & medicine, 181, 288-299. doi:10.1016/j.freeradbiomed.2022.02.015. https://pubmed.ncbi.nlm.nih.gov/35182729/
7. Cui, Xiaoteng, Zhao, Jixing, Li, Guanzhang, Fang, Chuan, Kang, Chunsheng. 2023. Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma. In Cancer communications (London, England), 43, 1326-1353. doi:10.1002/cac2.12502. https://pubmed.ncbi.nlm.nih.gov/37920878/
智鼠故事 
